Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Tumor targeting by surface-modified protein microspheres.

Toublan FJ, Boppart S, Suslick KS.

J Am Chem Soc. 2006 Mar 22;128(11):3472-3.

PMID:
16536492
2.

RGD-mediated delivery of small-molecule drugs.

Katsamakas S, Chatzisideri T, Thysiadis S, Sarli V.

Future Med Chem. 2017 Apr;9(6):579-604. doi: 10.4155/fmc-2017-0008. Epub 2017 Apr 10. Review.

PMID:
28394627
3.

Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting.

Meyer A, Auernheimer J, Modlinger A, Kessler H.

Curr Pharm Des. 2006;12(22):2723-47. Review.

PMID:
16918408
4.

Integrins in drug targeting-RGD templates in toxins.

Lu X, Lu D, Scully MF, Kakkar VV.

Curr Pharm Des. 2006;12(22):2749-69. Review.

PMID:
16918409
5.

Use of adhesion molecules for gene delivery.

Hart S.

Exp Nephrol. 1999 Mar-Apr;7(2):193-9. Review.

PMID:
10213873
6.

RGD and other recognition sequences for integrins.

Ruoslahti E.

Annu Rev Cell Dev Biol. 1996;12:697-715. Review.

PMID:
8970741
7.

Radiation-mediated control of drug delivery.

Hallahan DE, Qu S, Geng L, Cmelak A, Chakravarthy A, Martin W, Scarfone C, Giorgio T.

Am J Clin Oncol. 2001 Oct;24(5):473-80. Review.

PMID:
11586099
8.

Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins.

Takagi J.

Biochem Soc Trans. 2004 Jun;32(Pt3):403-6. Review.

PMID:
15157147
9.

RGD-based Therapy: Principles of Selectivity.

Rubtsov MA, Syrkina MS, Aliev G.

Curr Pharm Des. 2016;22(7):932-52. Review.

PMID:
26648463
10.

[RGD-peptides. Integrins. Desintegrins in osteoporosis treatment].

Petrovich IuA, Gurin NA, Gurin AN, Kichenko SM.

Patol Fiziol Eksp Ter. 2009 Apr-Jun;(2):37-40, inside back cover. Review. Russian. No abstract available.

PMID:
19537088

Supplemental Content

Support Center